Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Clinics in Dermatology
|
August 30, 2008
Fumaric acid esters
Martin Rostami Yazdi, Ulrich Mrowietz
Experimental Dermatology
|
January 25, 2011
Adipokines and psoriasis
Sascha Gerdes, Martin Rostami-Yazdi, Ulrich Mrowietz
Archives of Dermatological Research
|
June 25, 2010
Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients
Martin Rostami-Yazdi, Bernd Clement, Ulrich Mrowietz
Free Radical Biology & Medicine
|
July 7, 2009
Oxidative stress in the pathogenesis of psoriasis
Qiang Zhou, Ulrich Mrowietz, Martin Rostami-Yazdi
British Journal of Clinical Pharmacology
|
February 22, 2012
Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases
Rui Han, Martin Rostami-Yazdi, Sascha Gerdes, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 16, 2009
[15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris]
Ulrich Mrowietz, Martin Rostami-Yazdi, Marcus Neureither, et al.
The Journal of Investigative Dermatology
|
August 16, 2008
Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action
Martin Rostami-Yazdi, Bernd Clement, Thomas J Schmidt, et al.
Archives of Dermatological Research
|
March 26, 2013
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism
Stefan Dibbert, Bernd Clement, Tine Skak-Nielsen, et al.
Journal of Neuroinflammation
|
May 21, 2010
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation
Henrik Wilms, Jobst Sievers, Uta Rickert, et al.
Experimental Dermatology
|
December 14, 2011
Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Sascha Gerdes, Svetlana Osadtschy, Martin Rostami-Yazdi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Clinics in Dermatology
|
August 30, 2008
Fumaric acid esters
Martin Rostami Yazdi, Ulrich Mrowietz
Experimental Dermatology
|
January 25, 2011
Adipokines and psoriasis
Sascha Gerdes, Martin Rostami-Yazdi, Ulrich Mrowietz
Archives of Dermatological Research
|
June 25, 2010
Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients
Martin Rostami-Yazdi, Bernd Clement, Ulrich Mrowietz
Free Radical Biology & Medicine
|
July 7, 2009
Oxidative stress in the pathogenesis of psoriasis
Qiang Zhou, Ulrich Mrowietz, Martin Rostami-Yazdi
British Journal of Clinical Pharmacology
|
February 22, 2012
Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases
Rui Han, Martin Rostami-Yazdi, Sascha Gerdes, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 16, 2009
[15 years of fumaderm: fumaric acid esters for the systemic treatment of moderately severe and severe psoriasis vulgaris]
Ulrich Mrowietz, Martin Rostami-Yazdi, Marcus Neureither, et al.
The Journal of Investigative Dermatology
|
August 16, 2008
Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action
Martin Rostami-Yazdi, Bernd Clement, Thomas J Schmidt, et al.
Archives of Dermatological Research
|
March 26, 2013
Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism
Stefan Dibbert, Bernd Clement, Tine Skak-Nielsen, et al.
Journal of Neuroinflammation
|
May 21, 2010
Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation
Henrik Wilms, Jobst Sievers, Uta Rickert, et al.
Experimental Dermatology
|
December 14, 2011
Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Sascha Gerdes, Svetlana Osadtschy, Martin Rostami-Yazdi, et al.
Page
of 2